Dietz DK, Cook RF, Hendrickson A. Substance Use and Misuse. 2011. 46: 678-686. PMID: 21043788.
Summary: Female employees in two hospitals were invited to participate in this randomized controlled trial. Eligible participants (n=362) were randomized to either have immediate access to the SmartRx website, or to a wait-list control group. Participants in the SmartRx group had access to the program for 4 weeks. All participants completed an online, baseline survey about medication use, self-efficacy, attitudes, and interactions with physicians. These outcomes were assessed again at 6-months. At the 6-month follow-up, participants in the SmartRX group had greater knowledge about medications and greater gains in avoidance self-efficacy than the control group. No differences were found between groups on awareness of safe administration of prescriptions, physician-patient interactions, or knowledge of nondrug alternatives to promoting health. Additional analyses of items measuring drug problems indicated that participants completing the SmartRx program had lower drug misuse scores relative to those in the wait-list control group.
Take Away: Use of the SmartRx Web program is associated with increased knowledge about safe psychoactive prescription medication usage in working women. Further research should examine whether this program may decrease personal prescription drug misuse.